Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Incontinence, prolapse & sacral neuromodulation · Tennessee | Incontinence, prolapse & sacral neuromodulation · Florida | |
|---|---|---|
| Surgeons, 2024 | 43 | 107 |
| Medicare fee-for-service cases | 2,360 | 6,731 |
| Growth since 2019 (Medicare FFS) | −3.4%/yr | +0.7%/yr |
| Forecast cases (Medicare FFS) | 2,650 in 2030 | 7,480 in 2030 |
| Forecast growth | +1.9%/yr to 2030 | +1.8%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 3.3 | 3.0 |
| Medicare Advantage share | 57% | 60% |
| Out of hospital | 26% (+10 pts since 2019) | 30% (+10 pts since 2019) |
| Cases per surgeon | 55 | 63 |
| Top 10 surgeons' share | 51% | 30% |
| Surgeons growing | 3 | 13 |
| New since the base year | 5 | 20 |
| Likely to stop billing it | 4 by 2026 | 25 by 2026 |
| Forecast miss, 1 year (procedure) | 6% | 6% |
| Company payments per surgeon | $13K | $12K |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.